Ryu Kanzaki
Overview
Explore the profile of Ryu Kanzaki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
90
Citations
762
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Maniwa T, Ohue M, Kanzaki R, Shintani Y, Okami J
Gen Thorac Cardiovasc Surg
. 2024 Mar;
72(10):684-689.
PMID: 38498143
Objective: Segmentectomy and mediastinal lymph node dissection (LND) may increasingly be used for non-small cell lung cancer (NSCLC). Lymph node metastasis (LNM) distribution varies by lower lobe segments; however, its...
12.
Kanzaki R, Nagoya A, Taniguchi S, Ishida H, Kimura K, Fukui E, et al.
J Cardiothorac Surg
. 2024 Mar;
19(1):117.
PMID: 38475921
Background: There has been little information on the actual diagnosis of pulmonary lesions in patients with a history of urinary tract transitional cell carcinoma (TCC) and short- and long- outcomes...
13.
Kanzaki R, Watari H, Omura A, Kawagishi S, Tanaka R, Maniwa T, et al.
Interdiscip Cardiovasc Thorac Surg
. 2024 Mar;
38(3).
PMID: 38426364
Objectives: Information on prognostic factors after repeat pulmonary metastasectomy (PM) is limited, and outcomes after a third PM are not well documented. Methods: A single-institute retrospective study was conducted. Between...
14.
Kunimasa K, Matsumoto S, Honma K, Tamiya M, Inoue T, Kawamura T, et al.
BMC Pulm Med
. 2023 Dec;
23(1):484.
PMID: 38041137
Background: It is essential to collect a sufficient amount of tumor tissue for successful next-generation sequencing (NGS) analysis. In this study, we investigated the clinical risk factors for avoiding re-biopsy...
15.
Kunimasa K, Matsumoto S, Kawamura T, Inoue T, Tamiya M, Kanzaki R, et al.
Lung Cancer
. 2023 Apr;
179:107190.
PMID: 37058787
Introduction: To investigate the clinical performance of the AMOY 9-in-1 kit (AMOY) in comparison with a next-generation sequencing (NGS) panel in lung cancer patients. Methods: Lung cancer patients enrolled in...
16.
Ding Y, Zhang J, Zhuang W, Gao Z, Kuang K, Tian D, et al.
Eur Radiol
. 2022 Dec;
33(5):3092-3102.
PMID: 36480027
Objective: To construct a new pulmonary nodule diagnostic model with high diagnostic efficiency, non-invasive and simple to measure. Methods: This study included 424 patients with radioactive pulmonary nodules who underwent...
17.
Kunimasa K, Inoue T, Kai Y, Kanzaki R, Kawagishi S, Yoshida K, et al.
Thorac Cancer
. 2022 Nov;
14(1):85-88.
PMID: 36404408
Rapid and reliable identification of targetable driver mutations in patients with advanced stage lung cancer is essential. Adequate amount of tumor tissue biopsies (i.e., genomic biopsies) are required to successfully...
18.
Kunimasa K, Sugimoto N, Tamiya M, Inoue T, Kawamura T, Kanzaki R, et al.
Invest New Drugs
. 2022 Jun;
40(5):1137-1140.
PMID: 35657573
It has been reported that the efficacy of EGFR-TKI is predicted, not by which exon of the EGFR gene is mutated, but by the structural change in the EGFR protein...
19.
Nagoya A, Kanzaki R, Kimura K, Fukui E, Kanou T, Ose N, et al.
Interact Cardiovasc Thorac Surg
. 2022 May;
35(2).
PMID: 35640534
Objectives: The surgical Apgar score (SAS) is a simple score that predicts postoperative complications based on 3 intraoperative valuables. The present study evaluated the association between the SAS and postoperative...
20.
Wang S, Englund E, Kjellman P, Li Z, Kumra Ahnlide J, Rodriguez-Cupello C, et al.
Nat Cell Biol
. 2021 Jul;
23(7):758-770.
PMID: 34226698
The YAP/TAZ transcriptional programme is not only a well-established driver of cancer progression and metastasis but also an important stimulator of tissue regeneration. Here we identified Cerebral cavernous malformations 3...